40
Kevin Latinis, M.D./Ph.D. Division of Rheumatology Dept. of Internal Medicine Rheumatology Rheumatology 101: 101: What you need to What you need to know for your know for your ambulatory medicine ambulatory medicine experience experience

Rheum 101 Latin Is

Embed Size (px)

DESCRIPTION

Rheumatism ppt

Citation preview

Kevin Latinis, M.D./Ph.D.Division of RheumatologyDept. of Internal [email protected]

Rheumatology Rheumatology 101:101:

What you need to know What you need to know for your ambulatory for your ambulatory

medicine experiencemedicine experience

Rheumatology 101Rheumatology 101

ArthritisArthritis-Inflammatory (RA, spondyloarthropathies)-Inflammatory (RA, spondyloarthropathies)-Mechanical (OA)-Mechanical (OA)LupusLupusFibromyalgiaFibromyalgiaLow back pain and other peri-articular Low back pain and other peri-articular complaintscomplaintsGeneral musculoskeletal exam (time General musculoskeletal exam (time permitting)permitting)

Mechanical vs. Inflammatory ArthritisMechanical vs. Inflammatory Arthritis

Latinis, K., et al The Washington Manual Rheumatology Subspecialty Consult., LWW, 2003.

Osteoarthritis-BackgroundOsteoarthritis-Background

Very commonVery common-2-2ndnd leading cause for disability in USA leading cause for disability in USA-In patients 60 and older: affects 17% of -In patients 60 and older: affects 17% of men and 30% of womenmen and 30% of women-Estimated that 59.4 million patients will -Estimated that 59.4 million patients will have OA by the year 2020have OA by the year 2020EtiologyEtiology-primary idiopathic-primary idiopathic-secondary-secondary

Osteoarthritis-DistributionOsteoarthritis-Distribution

Latinis, K., Dao, K, Shepherd, R, Gutierrez, E, Velazquez, C. The Washington Manual Rheumatology Subspecialty Consult., LWW, 2003.

Bouchard’s

Heberden’s

Osteoarthritis-DiagnosisOsteoarthritis-Diagnosis

ClinicalClinical

Supported by X-raysSupported by X-rays

Non-inflammatory lab data, if anyNon-inflammatory lab data, if any

Osteoarthritis-TreatmentOsteoarthritis-Treatment

Pain reliefPain relief-Analgesics and NSAIDs/Cox-2 Inhibitors-Analgesics and NSAIDs/Cox-2 InhibitorsSMOADs (structure modifying osteoarthritis drugs)SMOADs (structure modifying osteoarthritis drugs)-Glucosamine Sulfate -Glucosamine Sulfate -see meta-analysis McAlindon et al. JAMA, 283: -see meta-analysis McAlindon et al. JAMA, 283: 3/2000, p. 14693/2000, p. 1469

-many under development-many under developmentNon-pharmacologic approachesNon-pharmacologic approaches-Reduce stress/load on joint-Reduce stress/load on joint-Strengthen surrounding muscles-PT/OT-Strengthen surrounding muscles-PT/OT-Weight reduction-Weight reduction-Patient education-Patient educationLimit disability and improve quality of lifeLimit disability and improve quality of life

Osteoarthritis-TreatmentOsteoarthritis-Treatment

Joint Replacement SurgeryJoint Replacement Surgery-Primarily of knee and hip, -Primarily of knee and hip, but also available in but also available in hands, shoulders,& elbows hands, shoulders,& elbows-Indications:-Indications:

1. pain at rest1. pain at rest2. instability2. instability

-patients benefit from -patients benefit from aggressive PT before & aggressive PT before & after surgery after surgery

Other surgical proceduresOther surgical procedures

Clinical Pearl:Clinical Pearl:Arthritis of the DIP jointArthritis of the DIP joint

OA (non-inflammatory)Psoriatic Arthritis (inflammatory)

Inflammatory ArthritisInflammatory Arthritis

Rheumatoid arthritisRheumatoid arthritisSpondyloarthropathiesSpondyloarthropathies-Undifferentiated-Undifferentiated-Ankylosing spondylitis-Ankylosing spondylitis-Psoriatic arthritis-Psoriatic arthritis-Reactive arthritis (formerly Reiter’s syndrome)-Reactive arthritis (formerly Reiter’s syndrome)-Enteropathic arthritis-Enteropathic arthritisSLE, Sjogrens, Scleroderma, Polymyalgia SLE, Sjogrens, Scleroderma, Polymyalgia rheumatica, Vasculitis, Infectious (bacterial, viral, rheumatica, Vasculitis, Infectious (bacterial, viral, other), Undifferentiated connective tissue other), Undifferentiated connective tissue diseasedisease

Latinis, K., et al The Washington Manual Rheumatology Subspecialty Consult., LWW, 2003.

Rheumatoid Arthritis-BackgroundRheumatoid Arthritis-Background

Symmetric, inflammatory polyarthritisSymmetric, inflammatory polyarthritis

Affects ~1% of our populationAffects ~1% of our population

Occurs in women 3x more than menOccurs in women 3x more than men

EtiologyEtiology-Genetic, class II molecules (HLA-DRB1)-Genetic, class II molecules (HLA-DRB1)-Autoimmune-Autoimmune-?Environmental-?Environmental

Rheumatoid Arthritis-DistributionRheumatoid Arthritis-Distribution

Latinis, K., et al The Washington Manual Rheumatology Subspecialty Consult., LWW, 2003.

Latinis, K., et al The Washington Manual Rheumatology Subspecialty Consult., LWW, 2003.

Definition-An inflammatory multisystem disease of unknown etiologywith protean clinical and laboratory manifestations and avariable course and prognosis.-Immunologic aberrations give rise to excessive autoantibodyproduction, some of which cause cytotoxic damage, whileothers participate in immune complex formation resulting inimmune inflammation.

Systemic Lupus Erythematosus Systemic Lupus Erythematosus (Lupus)-Background(Lupus)-Background

Clinical features-Clinical manifestations may be constitutional or result frominflammation in various organ systems including skin andmucous membranes, joints, kidney, brain, serous membranes,lung, heart and occasionally gastrointestinal tract.-Organ systems may be involved singly or in any combination.-Involvement of vital organs, particularly the kidneys andcentral nervous system, accounts for significant morbidityand mortality.-Morbidity and mortality result from tissue damage due tothe disease process or its therapy.

Systemic Lupus Erythematosus Systemic Lupus Erythematosus (Lupus)-Background(Lupus)-Background

Systemic lupus erythematosus classification criteria(SOAP BRAIN MD)

1. SSerositis: (a) pleuritis, or (b) pericarditis

2. OOral ulcers3. AArthritis4. PPhotosensitivity

10. MMalar rash11. DDiscoid rash

5. B Blood/Hematologic disorder: (a) hemolytic anemia or(b) leukopenia of < 4.0 x 109 (c) lymphopenia of < 1.5 x 109 (d) thrombocytopenia < 100 X

109

6. RRenal disorder: (a) proteinuria > 0.5 gm/24 h

or 3+ dipstick or(b) cellular casts

7. AAntinuclear antibody (positive ANA) 8. IImmunologic disorders:

(a) raised anti-native DNA antibody binding or(b) anti-Sm antibody or (c) positive anti-phospholipid antibody work-up

9. NNeurological disorder: (a) seizures or (b) psychosis

". ..A person shall be said to have SLE if four or more of the 11 criteria are present, serially or simultaneously, during any interval of observation."

53 yo BF with severe generalized weakness, weight loss, and chronic psychosis

Alopecia

Malar rash

Arthritis

Psychosis

Laboratory DataLaboratory Data

1394.3

10621

161.4

101 7.7

22.33.9

Absolute lymph=0.5

298

MCV=83

ESR=119CH50=67 (118-226)C3=31 (83-185)C4=18 (12-54)

ANA + 1:5280Anti DNA +Direct & Indirect Coombs +

Anti-IgG +

24 hour urineProtein=514

Treatment of SLETreatment of SLE

Arthritis, arthralgias, myalgias:Arthritis, arthralgias, myalgias:NSAIDS, anti-malarials (eg. NSAIDS, anti-malarials (eg. Plaquenil), Steroids-Plaquenil), Steroids-injections, oral methotrexateinjections, oral methotrexate

Photosensitivity, dermatitisPhotosensitivity, dermatitis avoid avoid Sun exposureSun exposuretopical steroidstopical steroidsPlaquenilPlaquenil

Weight loss and fatigueWeight loss and fatiguesteroidssteroids

Abortion, fetal lossAbortion, fetal loss ASAASA

immunosuppressionimmunosuppression

ThrombosisThrombosisanti-coagulantsanti-coagulants

GlomerulonephritisGlomerulonephritis steroidssteroidspulse cytotoxicspulse cytotoxics

mycophenylate mofetilmycophenylate mofetil

CNS diseaseCNS diseaseanti-coagulants for thrombosisanti-coagulants for thrombosis steroids and steroids and cytotoxics for cytotoxics for vasculitis vasculitis

Infarction (secondary to vasculitis)Infarction (secondary to vasculitis)steroidssteroids cytotoxicscytotoxics

prostacyclinprostacyclin

CytopeniasCytopeniassteroidssteroids IVIG-short IVIG-short term for term for thrombocytopeniathrombocytopenia danazoldanazol

cytotoxics-if bone cytotoxics-if bone marrow status marrow status is known is known

Steroids in LupusSteroids in Lupus

Steroid responsiveSteroid responsive Dermatitis Dermatitis (local)(local)

PolyarthritisPolyarthritisSerositisSerositisVasculitisVasculitisHematological Hematological Glomerulonephritis Glomerulonephritis

(most)(most)MyelopathiesMyelopathies

Steroid non-responsiveSteroid non-responsiveThrombosisThrombosisChronic renal damageChronic renal damageHypertensionHypertension Steroid-Steroid-inducedinduced psychosispsychosis InfectionInfection

Latinis, K., et al The Washington Manual Rheumatology Subspecialty Consult., LWW, 2003.

ANA-When to order and how to follow up on a positive test

Latinis, K., et al The Washington Manual Rheumatology Subspecialty Consult., LWW, 2003.

Fibromyalgia-BackgroundFibromyalgia-Background

Chronic musculoskeletal pain syndrome of Chronic musculoskeletal pain syndrome of unknown etiologyunknown etiology

Characterized by diffuse pain, tender Characterized by diffuse pain, tender points, fatigue, and sleep disturbancespoints, fatigue, and sleep disturbances

Prevalence is 2-5% with a female to male Prevalence is 2-5% with a female to male predominance of 8:1predominance of 8:1

Mean age is 30-60Mean age is 30-60

Fibromyalgia-DiagnosisFibromyalgia-Diagnosis

1

2

34

5

6

7

8

9

Fibromyalgia-TreatmentFibromyalgia-Treatment

Low back pain and Low back pain and other peri-articular complaints-other peri-articular complaints-

backgroundbackground

Very common, one of the most frequent reasons to visit Very common, one of the most frequent reasons to visit primary care physiciansprimary care physiciansArticular vs peri-articular problemsArticular vs peri-articular problems-Articular pain is generally deep or diffuse and worsens -Articular pain is generally deep or diffuse and worsens with active and passive motion with active and passive motion-Periarticular pain usually exibits point tenderness and -Periarticular pain usually exibits point tenderness and increased tenderness with active, but NOT passive increased tenderness with active, but NOT passive motion motion

Latinis, K., et al The Washington Manual Rheumatology Subspecialty Consult., LWW, 2003.

Latinis, K., et al The Washington Manual Rheumatology Subspecialty Consult., LWW, 2003.

Latinis, K., et al The Washington Manual Rheumatology Subspecialty Consult., LWW, 2003.

Muscles of the rotator cuff:SupraspinatusInfraspinatusSubscapularisTeres Minor

Low back pain and Low back pain and other peri-articular complaints-other peri-articular complaints-

TreatmentTreatment

RICERICE-Rest-Rest-Ice-Ice-Compression-Compression-Elevation-Elevation

NSAIDs and NSAIDs and analgesics analgesics

TimeTime

OtherOther

General Musculoskeletal ExamGeneral Musculoskeletal Exam

Underutilized by primary care providersUnderutilized by primary care providers

Should be simple and quickShould be simple and quick

Goal is to recognize signs of Goal is to recognize signs of rheumatological diseases and determine if rheumatological diseases and determine if it is appropriate to refer to a it is appropriate to refer to a rheumatologist or manage independentlyrheumatologist or manage independently

SummarySummary

ArthritisArthritis-Inflammatory (RA, spondyloarthropathies)-Inflammatory (RA, spondyloarthropathies)-Mechanical (OA)-Mechanical (OA)LupusLupusFibromyalgiaFibromyalgiaLow back pain and other peri-articular Low back pain and other peri-articular complaintscomplaintsGeneral musculoskeletal exam (time General musculoskeletal exam (time permitting)permitting)